Cerevel Therapeutics Holdings, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 APLS
|
Apellis Pharmaceuticals, Inc. | $28.80 | $4.90 B | -11.77 | 702 | $396.59 M |
 BPMC
|
Blueprint Medicines Corporation | $92.51 | $6.47 B | -21.48 | 638 | $249.38 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.73 | $1.29 B | -7.16 | 85 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.91 | $1.12 B | -5.11 | 169 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.39 | $217.51 M | -3.7 | 57 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.29 | $243.38 M | -1.59 | 129 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $43.81 | $2.47 B | -23.59 | 136 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.12 | $151.66 M | -3.17 | 45 | $19.94 M |
 IGMS
|
IGM Biosciences, Inc. | $16.72 | $485.17 M | -1.95 | 204 | $2.13 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.09 | $652.38 M | -6.03 | 28 | $0 |
 NUVL
|
Nuvalent, Inc. | $102.34 | $5.11 B | -32.72 | 115 | $0 |
 RNA
|
Avidity Biosciences, Inc. | $45.93 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $45.34 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.29 | $774.50 M | -6.14 | 110 | $8.78 M |
 SWTX
|
SpringWorks Therapeutics, Inc. | $32.04 | $2.98 B | -7.81 | 305 | $5.45 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.32 | $462.44 M | -5.67 | 66 | $0 |
 TVTX
|
Travere Therapeutics, Inc. | $13.98 | $542.80 M | -1.32 | 380 | $145.24 M |
 VTYX
|
Ventyx Biosciences, Inc. | $2.19 | $229.83 M | -1.01 | 73 | $0 |